2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Objective measurement in clinical care of patients with Parkinson’s disease

M. Horne, K. Kotschet, M. Braybrook (Parkville, Australia)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Objective measures of Parkinsonian motor symptoms using a continuously worn smartwatch

N. Fixler, L. Reitblat, A. Wagner, S. Cohen, M. Afek, P. Bonato, J.F. Daneault, N. Golabchi, S. Moore, A. Patel, C. Cho, L. Bataille (Petach Tikva, Israel)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Ocular flutter in alcohol withdrawal syndrome

K.P. Frei, M. Dastjerdi, F.B. Pedouim, L.H. Sovory, K. Dashtipour (Loma Linda, CA, USA)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

N.K. Majbour, N.N. Vaikath, K.D. Dijk, M. Ardah, C.E. Teunissen, H.W. Berendse, W.D.J. Berg, O.M.A. El-Agnaf (Amsterdam, Netherlands)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Onset and stabilization of opicapone treatment effects in fluctuating Parkinson’s disease patients: Exploratory by-week efficacy analysis of pooled phase III studies

A. Lees, J. Ferreira, H. Reichmann, E. Tolosa, A. Santos, C. Oliveira, I. Oliveira, N. Lopes, J.F. Rocha, P. Soares-da-Silva (London, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Opicapone in fluctuating Parkinson’s disease patients: OFF- and ON-time responder post-hoc analyses of pooled phase III studies

A. Lees, J. Ferreira, T. Müller, F. Stocchi, C. Oliveira, A. Santos, N. Lopes, J.F. Rocha, P. Soares-da-Silva (London, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Orientation of attention affects onset of head saccades: A novel representation of the Posner cueing effect

I.M. Beiser, B. Quinlivan, E. McGovern, L.J. Williams, S. Narasimham, O. Killian, R. Beck, S. O'Riordan, J.S. Butler, R.B. Reilly, M. Hutchinson (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy

L.E. Katus, S.J. Frucht (New York, NY, USA)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Osteopathic manipulative treatment in Parkinson’s disease: Preliminary results of a double blind sham-controlled cross-over study

S. Varanese, L. Cicchitti, G. Travaglini, V. Carafa, N. Modugno, S. Spinelli, F. Marsicano, M. Mistichelli, F. Marsicano, F. Giorgini, M. Verzella (Pozzilli, Italy)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Outpatient management of Parkinson’s disease: A review of medication changes made to address both motor and non-motor symptoms

B. Magennis, E.A. Donlon, E.M. Fallon, T. Lynch (Dublin, Ireland)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2